Skip to main content

Cardiovascular Thrombus

From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions

  • 1st Edition - August 18, 2018
  • Latest edition
  • Editor: On Topaz
  • Language: English

Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions provides a comprehensive, up-to-date presentation of the research… Read more

Data Mining & ML

Unlock the cutting edge

Up to 20% on trusted resources. Build expertise with data mining, ML methods.

Description

Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions provides a comprehensive, up-to-date presentation of the research and clinical practices as related to the contemporary aspects of the diagnosis and management of cardiovascular thrombosis. The formation, identification and management of cardiovascular thrombus is of paramount importance for researchers and practicing physicians, yet it remains one of the most challenging diagnostic and clinical scenarios. This important reference connects between research, up-to-date clinical knowledge, and the technological tools available for diagnosis and management of thrombus in cardiovascular medicine. The book includes comprehensive descriptions and review of pathology, clinical presentations, diagnosis, pharmacotherapy, interventions and future trends.
It is the perfect reference for basic science students and researchers in general and interventional cardiology, general and interventional radiology, vascular medicine specialists, and vascular, general and cardiac surgeons.

Key features

  • Provides comprehensive presentation of the pathophysiology, clinical presentations and diagnosis of cardiovascular thrombosis
  • Includes the most up-to-date information on the practical management of patients with thrombus related conditions
  • Written by the leading experts in the field
  • Describes the current and upcoming pharmacotherapy and technology available for thrombus research and treatment

Readership

Basic science researchers, and clinicians in cardiology, radiology, hematology, interventional and vascular medicine specialists, vascular and cardiac surgeons as well as residents and fellows-in–training in medicine, radiology, hematology, cardiology and surgery.

Table of contents

Section 1. Pathology

1. Histopathology of cardiovascular thrombus
Hiroyuki Jinnouchi and Renu Virmani

2. Pathology of Arterial Thrombosis: Characteristics and Thrombus Types
George S. Abela

3. Fibrin clot structure and function: a novel risk factor for arterial and venous thrombosis and thromboembolism
Robert Ariens and Stephen R. Baker

4. The role of platelets in the pathophysiology of atherosclerosis and its complications
Albert Ferro, Kerry Layne and Gabriella Passacquale

5. Mathematical models of thrombus formation and fibrinolysis
Karin Leiderman, Brittany Bannish, Michael A. Kelley and Ada Palmisano

6. Animal models of thrombosis
Gemma Vilahur

7. Imaging Modalities for Detection and Treatment of Cardiovascular Thrombus
Claudia A. Martinez, Rodrigo Mendirichaga and Joel Fishman

8. Utilization of MRI/MRA for cardiac thrombus
Rhoda Brosnan

9. Acute Myocardial Infarction: STEMI and NSTEMI
Peter O’Kane and Kalpa De Silva

10. Acute Coronary Syndrome: thrombotic lesions in patients with unstable angina
Ion S. Jovin, Gabriele Cioni and Nayef A. Abouzaki

11. Practical perspectives on the guidelines for management of coronary thrombus
Elliott Smith

12. Thrombus classifications – critical tool for diagnostic and interventional cardiovascular procedures
On Topaz

13. Impact of thrombus burden on myocardial damage in the setting of primary PCI
Massimo Napodano and Antonio Landi

14. The impact of thrombus as a cause and as a result of complicated PCI
Emmanouil S. Brilakis

Section 2. Clinical presentations

15. Stent Thrombosis: Early, Late and Very Late
Thomas E. Watts III, Massoud Leesar and Arka Chatterjee

16. STENT THROMBOSIS: IMPLICATIONS ON NEW STENT DESIGNS AND DAPT DURATION
Dean Kereiakes

17. Aspiration catheters & Protection filters
Anthony A. Bavry and Dhruv Mahtta

18. Power sourced mechanical thrombectomy in the management of thrombus-containing atherosclerotic lesions
On Topaz

19. Dedicated thrombus-containing stent platforms
Ran Kornowski

20. Dissolution of thrombus with ultrasound: a journey through physics, basic research and clinical utilization
Uri Rosenschein

21. The role and impact of thrombus in formation and revascularization of chronic total occlusions
On Topaz

22. Interventions in a spectrum of thrombotic lesions: real life experience in the cardiac catheterization suites of a large size tertiary care center
P.P.T. de Jaegere

23. Atrial fibrillation : Prevalence, types, and clinical implications
Gregory K. Jones

24. Acute and chronic pulmonary embolism: perspectives on diagnosis and management
Mordechai Reuven Kramer and Avraham Unterman

25. Surgical management of cardiovascular thrombotic conditions
Tomas A. Salerno

Section 3. Diagnosis

26. The spectrum of clinical presentations and management options for the treatment of degenerative atherothrombotic disease of saphenous vein grafts
Haim Danenberg

27. Prosthetic Heart Valve Thrombosis
Felipe Albuquerque, Eduardo De Marchena and Giselle Baquero

28. EXPERIMENTAL DESIGNS FOR IN VITRO ASSESSMENT OF VALVE THROMBOSIS
Ali N. Azadani and Danny Dvir

Section 4. Treatment Guidelines

29. Ventricular Assist Device Thrombosis: Past, Present and Future
Neil Pendril Lewis

Section 5. Pharmacotherapy

30. Vascular Closure Devices and Thrombosis
Brian Clapp and Matthew James Ryan

31. Management strategies for thrombosis of major abdominal aortic branches: the superior mesenteric and renal arteries
Mohammed Aladdin

32. Thrombotic lesions in the lower extremity peripheral arteries: diagnosis and management
Nicolas W. Shammas

33. Venous Thrombosis
David Hirschl

34. Revascularization for acute ischemic stroke: contemporary perspectives on the role and yield of thrombolytic therapy and endovascular intervention
Larry B. Goldstein

35. Treatment Options for Recurrent Thromboembolism in Patients with Cryptogenic Cerebrovascular Events: Medical Therapy versus Device closure or Surgical repair of Patent Foramen Ovale
Andres Pineda and J. Kevin Harrison

Section 6. Interventions

36. Left Atrial Appendage Occluders – recent advances and unresolved issues
Michael Glikson and Arwa Younis

37. Thrombophilia – contemporary perspectives
Srikanth Nagalla

38. Infectious diseases and cardiovascular thrombosis
Subhashis Mitra and Daniel Havlichek Jr.

39. Thrombosis in Pregnancy
Michael Lishner and Ron Hoffman

40. The Role of Interventional Cardiology in the Management of Thrombotic Conditions in the Pediatric Population
Satinder K. Sandhu

41. Kawasaki disease – the phenomenon of thrombotic coronary and vascular aneurysms in the young and adults - a Japanese perspective
Takayuki Onishi

42. Thrombus Pharmacotherapy
Sunil V. Rao, Holly L. Humphrey and James Anderson Smith

Section 6. Future trends

43. Antithrombotic Treatment in Patients Undergoing Transcatheter Aortic Valve Replacement
Amit Segev and Elad Asher

44. Antifibrinolytics: Pharmacologic Profile and Clinical Utilization
Elizabeth Landrum Michalets

45. The Realm of Drugs, Biological Products, and Supplement Induced Thrombosis and Thromboembolic Risk
Brian Peek, Emily E. Wood and Benjamin Michalove

Product details

  • Edition: 1
  • Latest edition
  • Published: August 18, 2018
  • Language: English

About the editor

OT

On Topaz

Professor Topaz’s main clinical specialty is percutaneous interventions for complex lesion subsets in challenging coronary and peripheral vascular targets. He specializes in treatment of patients with critical lesions in the presence of depressed LVEF, severe left main disease, old saphenous vein grafts, chronic total occlusions, stent thrombosis and heart transplant allograft disease. He has special interest in revascularization of severe renal artery stenosis and severe subclavian artery occlusions. Professor Topaz is the inventor of several percutaneous revascularization techniques with advanced debulking technology for plaque extraction and thrombus removal. He is also a national and international proctor of FDA approved plaque debulking and thrombectomy devices such as laser and rheolytic thrombectomy.

Professor Topaz is a world authority on cardiovascular lasers whereby he pioneered the contemporary coronary lasing techniques and introduced the utilization of laser revascularization in acute myocardial infarction. In addition, he developed laser application for treatment of congenital heart conditions such as pulmonic atresia. Professor Topaz conducts basic research on the effects of laser irradiation on cardiac and vascular bio-tissue with special focus on the interaction of laser energy with thrombus and platelets. He discovered the unique phenomena of laser- induced enhancement of thrombolytic agents activity and laser induced suppression of platelet aggregation. Clinically , he investigates the therapeutic outcomes of various cardiovascular lasers.

Professor Topaz is a recognized researcher and scholar of cardiovascular pathology and vascular anatomy. In 2010 he discovered in several patients the existence of a previously unknown, peripheral artery which constitutes origin of both inferior phrenic arteries as a vascular trunk from the right renal artery. The importance of this discovery was further emphasized as this vessel supplies unique, also newly discovered trans diaphragmatic cardiac collaterals. Recently, he and colleagues introduced an important paradigm shift in the diagnosis and management of symptomatic chronic mesenteric ischemia with emphasis on the performance of endovascular interventions in the inferior mesenteric artery.

Professor Topaz served on special study sections of the NIH and NSF and is a fellow of the American College of Cardiology, the American College of Physicians, the Society for Cardiac Angiography and Interventions, the American Society of Laser Medicine and Surgery, the Society of Vascular Medicine and a member of numerous cardiovascular societies and organizations. Professor Topaz is an invited faculty of leading international conferences in the field of interventional cardiology, whereby he participates as live case operator, lecturer, moderator, discussant and session chairperson . He has lectured, proctored and performed live coronary and peripheral interventions in many countries around the world. Between 1998 and 2005 he served as the North American Editor- in- Chief of the journal Laser in Medical Sciences, the clinical publication of the European Laser Association. He is the recipient of an NIH national research service award, the Winthrop interventional award and several teaching awards. In 2010 the McGuire Veterans Affairs medical center of Virginia Commonwealth University established the “On Topaz MD award”, presented annually to their best interventional cardiology fellow. To date, Professor Topaz has published 137 peer-reviewed articles; the textbook “Lasers in Cardiovascular interventions [Springer, UK, 2016]; the textbook "Cardiovascular Thrombus" [Elsevier, Philadelphia, USA, 2018]; 31 book chapters and a member of 18 peer-reviewed journals.23 book chapters and 56 abstracts. He is a reviewer and editorial board member of 16 peer-reviewed journals and a member of medical advisory boards.

Affiliations and expertise
Professor of Medicine, School of Medicine, Duke University, Cardiologist, Division of Cardiology, Charles George Veterans Affairs Medical Center, Asheville, NC, USA

View book on ScienceDirect

Read Cardiovascular Thrombus on ScienceDirect